Envveno Medical Corp Stock Piotroski F Score
| NVNO Stock | USD 5.06 0.03 0.59% |
EnVVeno | Piotroski F Score |
At this time, it appears that EnVVeno Medical's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
| Current Return On Assets | Negative |
| Change in Return on Assets | Decreased |
| Cash Flow Return on Assets | Negative |
| Current Quality of Earnings (accrual) | Improving |
| Asset Turnover Growth | Decrease |
| Current Ratio Change | Increase |
| Long Term Debt Over Assets Change | N/A |
| Change In Outstending Shares | Increase |
| Change in Gross Margin | Increase |
EnVVeno Medical Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to EnVVeno Medical is to make sure EnVVeno is not a subject of accounting manipulations and runs a healthy internal audit department. So, if EnVVeno Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if EnVVeno Medical's financial numbers are properly reported.
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0099 | 0.0105 |
|
| |||||
| Total Current Liabilities | 2.3 M | 1.4 M |
|
| |||||
| Non Current Liabilities Total | 1.5 M | 1.1 M |
|
| |||||
| Total Assets | 51.1 M | 48.6 M |
|
| |||||
| Total Current Assets | 49.3 M | 46.9 M |
|
|
enVVeno Medical Corp F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between EnVVeno Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards EnVVeno Medical in a much-optimized way.
Click cells to compare fundamentals
About EnVVeno Medical Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value Per Share |
|
EnVVeno Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of EnVVeno Medical from analyzing EnVVeno Medical's financial statements. These drivers represent accounts that assess EnVVeno Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of EnVVeno Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 8.7M | 11.2M | 57.2M | 57.3M | 63.2M | 66.4M | |
| Enterprise Value | 8.2M | 2.7M | 4.5M | 54.4M | 61.0M | 64.1M |
About EnVVeno Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze enVVeno Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EnVVeno Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of enVVeno Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EnVVeno Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EnVVeno Medical's short interest history, or implied volatility extrapolated from EnVVeno Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out EnVVeno Medical Altman Z Score, EnVVeno Medical Correlation, EnVVeno Medical Valuation, as well as analyze EnVVeno Medical Alpha and Beta and EnVVeno Medical Hype Analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for EnVVeno Stock analysis
When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Return On Assets (0.35) | Return On Equity (0.55) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.